Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study
Fiona Horan(Emory University), Elizabeth Stenger(Emory University), Rikin Shah(Center for Children), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Monica Bhatia(Columbia University Irving Medical Center), Katie Liu(Emory University), Allistair Abraham(Children's National), Glenda N. Bendiak(University of Calgary), Deepak Chellapandian(Johns Hopkins University), John Horan(Emory University), Michael J. Eckrich(Levine Children's Hospital), Sonali Chaudhury(Northwestern University), Gregory M.T. Guilcher(University of Calgary), Alexander Ngwube(Children's Cancer Center), Jennifer Jaroscak(Medical University of South Carolina), Scott Gillespie(Emory University), Shalini Shenoy(Washington University in St. Louis), Lakshmanan Krishnamurti(Emory University), Jennifer Krajewski
Cited by 1
Related Papers
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
|American Journal of Respiratory and Critical Care Medicine|2014|256
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|255
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248